◆ 会议时间：2023年9月27日至30日
◆ 会议地点：美国 费城
◆ 会议简介：
2023年北美更年期学会（NAMS）年会将于2023年9月27日至30日在美国宾夕法尼亚州费城举行，预计有超过1200名专业人士出席会议。
北美更年期学会（NAMS）成立于1989年，是北美洲领先的非营利性多学科组织，致力于通过对更年期和健康老龄化的了解，提高所有中年及以后女性的健康和生活质量。NAMS现拥有2000多名宣在该领域知名的多学科成员，他们是来自于医学、护理、社会学、心理学、营养学、人类学、流行病学、药学和教育方面的临床和基础科学专家。NAMS推出了多个更年期女性健康指南，成为其他国家制定自身指南的重要参考资源（未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
NAMS 2023 - North American Menopause Society Annual Scientific Meeting
Date: September 27-30, 2023
Venue:
Marriott Downtown Philadelphia, PA USA
摘要征文投稿：
点此提交摘要>>>Submit Abstract>>>
The deadline for regular submission is April 30, 2023. The deadline for late-breaking submission is July 1, 2023. Guidelines follow:
- Each author may submit up to five abstracts for consideration.
- There is a limit of 4,545 characters for the text of your submission. The character count includes spaces, title, authors, institutions, tables, and images. You will be advised of your character count usage throughout the submission process as you save and move to the next step. Your character count will also be displayed in the bar at the top of your submission.
- Information submitted for consideration must not be identical to that presented at any meeting prior to the NAMS Annual Meeting and the study must not have been published as of the submission date.
- Authors who wish to be considered for a New Investigator Award must have earned their degree within seven years, and not previously been given this award. Proof of eligibility is required.
- All abstracts presented at the NAMS Annual Meeting will be published in Menopause.
- NAMS reserves the right not to review an abstract, or not to publish an abstract in Menopause, if the abstract submission does not conform to all requirements.
- Abstracts must be submitted in English, in a structured format.
- Late-breaking submissions must be truly late-breaking, meaning the material was not available for submission by the regular deadline of April 30, 2023.
Types of Presentations
- Oral Presentation: The top scoring abstracts will be invited to be presented from the podium in a Scientific Session held during the NAMS Annual Meeting.
- Poster Presentation: All other abstract submissions will be considered for poster presentation during the Poster Session. Up to three Poster Prizes will be awarded, with a top prize of $1,000.
Review and Selection Process
All abstracts are subjected to a blinded review by three independent members of the NAMS Abstract Review Committee. After being sent to the Abstract Review Committee for review, submissions may not be altered. Abstracts will be scored as follows:
- Approach
- Innovation
- Impact of study findings on field of menopause
- Clarity
Approach: Is the study design appropriate to the study aims? How strong are the research methods with respect to selection of participants (inclusion/exclusion) and procedures used to assess outcome measures? Is the analytic approach appropriate to the study goals? Do the study conclusions flow from the results? Are study limitations recognized?
Innovation: Does the project challenge and shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation or interventions?
Impact of Study: Does the project address an important problem or a critical barrier to progress in the field of women's health at midlife and beyond? Does the project improve scientific knowledge, technical capability and/or clinical practice? Does the project change the concepts, methods technologies, treatments, services, or preventative interventions that drive the field of women's health at midlife and beyond?
Clarity: Is the research study presented in a clear and easily understandable manner? Are the goals of the science, the findings, and the interpretation readily accessible to the audience?
Notification of Receipt and Acceptance
- Receipt of abstract submissions will be acknowledged via email to the contact author.
- After the review process is complete, authors will be notified by June 15, 2023, regarding the acceptance or rejection of their submissions. Late-breaking notifications will be sent at a later date.
Information for Presenters
Both oral and poster presentations can find details regarding their presentations here.
Cancellations
Authors of accepted presentations who do not present their work or fail to have it presented by a co-author will not be permitted to have abstracts considered for presentation at the NAMS Annual Meeting for the following two years. Exceptions will be considered if NAMS is given prompt notification of extreme unforeseen circumstances.
注册费：
REGISTRATION FEES IN-PERSON MEETING
Menopause 101 Course
Tuesday (September 26–1:00 PM to 5:15 PM)
| NAMS Member |
|
$200 |
| Nonmember |
|
$275 |
| In-Training |
|
$100 |
Medical Breast and Genetics 101 Course
(This course is limited to 200 attendees)
Tuesday (September 26–1:00 PM to 5:00 PM)
| NAMS Member |
|
$200 |
| Nonmember |
|
$275 |
| In-Training |
|
$100 |
Annual Meeting—NAMS 2023: Midlife Women’s Health in the Era of Precision Medicine
The registration fees for the Annual Meeting include attendance to the main program and access to the Opening Symposium—Precision Oncology for Midlife Women
Wednesday to Saturday (September 27-30)
In-person registration fees for the Annual Meeting, including the Opening Symposium, also provide access to these activities virtually, through OnDemand.
| NAMS Member |
|
$700 |
| Nonmember |
|
$1,000 |
| In-Training |
|
$350 |
| Guest |
|
$100 |
REGISTRATION FEES VIRTUAL MEETING
Menopause 101 Course
| NAMS Member |
|
$200 |
| Nonmember |
|
$275 |
| In-Training |
|
$100 |
Medical Breast and Genetics 101 Course
| NAMS Member |
|
$200 |
| Nonmember |
|
$275 |
| In-Training |
|
$100 |
Annual Meeting—NAMS 2023: Midlife Women’s Health in the Era of Precision Medicine
and Opening Symposium—Precision Oncology for Midlife Women
| NAMS Member |
|
$700 |
| Nonmember |
|
$1,000 |
| In-Training |
|
$350 |
CANCELLATION
Cancellation notices for the in-person events received by August 31, 2023, will receive a 75% refund. No refund will be given after that date.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
